Summary
- Current Price
- As of today, AGIO price is $27.96, down -0.39% on
- Current Price All-Time High
- AGIO price is currently -79.86% below its historical high of $138.85 set on
- Market Cap
- AGIO current market cap is $2B, down -14.54% year-over-year
- PE Ratio
- AGIO PE ratio is unknown
- Revenue
- AGIO current annual revenue is $36.50M, up +36.07% year-over-year
- Next Earnings
- As of today, the next earnings release for AGIO has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Agios Pharmaceuticals, Inc. |
| Ticker | NASDAQ: AGIO |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | agios.com |
| Employees | 486 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $27.96 | |
| Price, 1D Change | -0.39% | |
| $2B | ||
| - | ||
| - | ||
| 0.89 | ||
| $36M | ||
| Revenue, 1Y Change | +36.07% | |
| $11.64 | ||
| EPS, 1Y Change | +283.95% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| $11.64 | ||
| EPS Estimate | N/A | -$7.01 |
| EPS Est. Change | N/A | -160.23% |
| $36.50M | ||
| Revenue Estimate | N/A | $46.12M |
| Revenue Est. Change | N/A | +26.37% |
| Current Price | $27.96 | |
| Price Target | - | $36.50 |
| Price Tgt. Change | - | +30.54% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $11.21 | $11.64 | +3.82% | |
| -$7.01 | N/A | -160.23% | |
| -$6.50 | N/A | -155.88% | |
| -$5.31 | N/A | -145.59% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $35.16M | $36.50M | +3.79% | |
| $46.12M | N/A | +26.37% | |
| $96.32M | N/A | +163.91% | |
| $213.54M | N/A | +485.07% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $27.96 | |
| $34.08 | ||
| SMA 200 vs Price | +21.89% | |
| $27.38 | ||
| SMA 50 vs Price | -2.06% | |
| 0.89 | ||
| $1.26 | ||
| 51.38 | ||
| 30.76% | ||
| 70.47% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $36.50M | ||
| $11.64 | ||
| $26.68M | ||
| 73.10% | ||
| -$425.74M | ||
| -1,166.47% | ||
| $673.73M | ||
| - | ||
| -$420.08M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 11.90 | ||
| 11.56 | ||
| - | ||
| 3 | ||
| 7.69 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 36.40 | ||
| 1.27 | ||
| -1.54 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $1.54B | ||
| $76.25M | ||
| $1.66B | ||
| $965.60M | ||
| $122.24M | ||
| $81.16M | ||
| $56.99M | ||
| $16.78M | ||
| $16.64M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $462.24M | ||
| $458.07M | ||
| $9.82M | ||
| $156.78M | ||
| $5.65M | ||
| $0.00 | ||
| $44.24M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$389.84M | ||
| $363.44M | ||
| $14.44M | ||
| $1.69M | ||
| -$391.53M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| JP Morgan | → | |
| Leerink Partners | → | |
| Truist Securities | → | |
| HC Wainwright & Co. | → | |
| B of A Securities | → | |
| Citigroup | ||
| Truist Securities | ||
| JP Morgan | → | |
| RBC Capital | → |
Analyst sentiment
Institutional ownership
Screeners with AGIO
FAQ
What is the ticker symbol for Agios Pharmaceuticals, Inc.?
The ticker symbol for Agios Pharmaceuticals, Inc. is NASDAQ:AGIO
Does Agios Pharmaceuticals, Inc. pay dividends?
No, Agios Pharmaceuticals, Inc. does not pay dividends
What sector is Agios Pharmaceuticals, Inc. in?
Agios Pharmaceuticals, Inc. is in the Healthcare sector
What industry is Agios Pharmaceuticals, Inc. in?
Agios Pharmaceuticals, Inc. is in the Biotechnology industry
What country is Agios Pharmaceuticals, Inc. based in?
Agios Pharmaceuticals, Inc. is headquartered in United States
When did Agios Pharmaceuticals, Inc. go public?
Agios Pharmaceuticals, Inc. initial public offering (IPO) was on July 24, 2013
Is Agios Pharmaceuticals, Inc. in the S&P 500?
No, Agios Pharmaceuticals, Inc. is not included in the S&P 500 index
Is Agios Pharmaceuticals, Inc. in the NASDAQ 100?
No, Agios Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
Is Agios Pharmaceuticals, Inc. in the Dow Jones?
No, Agios Pharmaceuticals, Inc. is not included in the Dow Jones index
When was Agios Pharmaceuticals, Inc. last earnings report?
Agios Pharmaceuticals, Inc.'s most recent earnings report was on February 12, 2026
When does Agios Pharmaceuticals, Inc. report earnings?
The date for Agios Pharmaceuticals, Inc.'s next earnings report has not been announced yet
Data Sources & References
- AGIO Official Website www.agios.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1439222/000143922225000116/0001439222-25-000116-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1439222/000143922225000009/0001439222-25-000009-index.htm
- AGIO Profile on Yahoo Finance finance.yahoo.com/quote/AGIO
- AGIO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/agio